Search Results 21-30 of 14348 for Assay

  1. Diagnostic and Prognostic Validity of Tissue-based Biomarker Assay for Acute Graft-versus-host Disease of the Skin: A Retrospective Study - Mayo Clinic

    ... assay, the aim is to perform a multi-institution, retrospective study of our assay compared with the current clinical gold standard (clinicopathologic ...

  2. Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol - Mayo Clinic

    Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol · Overview · Participation eligibility · Participating Mayo Clinic ...

  3. CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung (DELFI-L201) - Mayo Clinic

    CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung (DELFI-L201). Print details. Share; Facebook · Twitter. Overview ...

  4. Novel MOG assay aids diagnosis of demyelinating diseases - Mayo Clinic

    Novel MOG assay aids diagnosis of demyelinating diseases · Mayo Clinic has developed the first test available in the US to identify the myelin oligodendrocyte ...

  5. Clinical Biochemical Genetic Assays Associated with Inborn Errors of Metabolism and Other Heritable or Congenital Conditions

    The objectives of this protocol are to develop and validate clinical assays for inborn errors of metabolism (IEMs) using specimens collected from consenting ...

  6. Detection of Recurrent Colorectal Cancer by Assay of Novel Methylated DNA Markers in Plasma - Mayo Clinic

    To evaluate the ability of the plasma MDM assay to predict CRC recurrence when tested serially following curative resection of CRC metastases. Participation ...

  7. Detection of Mutant Circulating Tumor (CT)Dna in Uveal Melanoma With Development of a Droplet Digital Pcr (Ddpcr) Assay - Mayo Clinic

    ... assay for the detection of mutations associated with uveal melanoma. The performance characteristics of the ddPCR assay for the detection of ctDNA mutation ...

  8. Services - Targeted Biomarker Core - Immunochemical Core

    If the test is available on an existing platform in the Targeted Biomarker Core, the core can perform the assay if the number of samples is sufficient and with ...

  9. Cell Free DNA (Cfdna) Blood Assays for the Detection of EGFR and Other Clinically Relevant Gene Mutations in Patients with Non-Small Cell Lung Cancer - Mayo Clinic

    The objective of this study is to validate internally developed assays for the detection of clinically relevant gene mutations in cfDNA from the peripheral ...

  10. Fecal calprotectin assay performs well as biomarker for measurement of ulcerative colitis disease activity - Mayo Clinic

    ... assay methods. To further examine FC's potential as a biomarker for disease activity in UC, Dr. Loftus and colleagues conducted a retrospective observation ...